Jeremy Travins

Person

Southborough, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Plasma kallikrein inhibitors and uses thereof
- Patent number 12,221,441
- Issue date Feb 11, 2025
- Takeda Pharmaceutical Company Limited
- Nikolaos Papaioannou
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaryl plasma kallikrein inhibitors
- Patent number 12,065,448
- Issue date Aug 20, 2024
- Takeda Pharmaceutical Company Limited
- Nikolaos Papaioannou
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of cellular metabolic processes
- Patent number RE49934
- Issue date Apr 23, 2024
- Servier Pharmaceuticals LLC
- Zenon D. Konteatis
Information Patent Grant
Inhibitors of plasma kallikrein and uses thereof
- Patent number 11,905,285
- Issue date Feb 20, 2024
- Takeda Pharmaceutical Company Limited
- Jeremy Travins
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutically active compounds and their methods of use
- Patent number 11,844,758
- Issue date Dec 19, 2023
- SERVIER PHARMACEUTICALS LLC
- Zenon Konteatis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Plasma Kallikrein inhibitors and uses thereof
- Patent number 11,787,796
- Issue date Oct 17, 2023
- Takeda Pharmaceutical Company Limited
- Nikolaos Papaioannou
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutically active compounds and their methods of use
- Patent number 11,667,673
- Issue date Jun 6, 2023
- SERVIER PHARMACEUTICALS LLC
- Janeta Popovici-Muller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterobicyclic inhibitors of MAT2A and methods of use for treating...
- Patent number 11,524,960
- Issue date Dec 13, 2022
- SERVIER PHARMACEUTICALS LLC
- Zenon D. Konteatis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutically active compounds and their methods of use
- Patent number 11,505,538
- Issue date Nov 22, 2022
- SERVIER PHARMACEUTICALS LLC
- Giovanni Cianchetta
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaryl plasma kallikrein inhibitors
- Patent number 11,370,803
- Issue date Jun 28, 2022
- Takeda Pharmaceutical Company Limited
- Nikolaos Papaioannou
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of plasma kallikrein and uses thereof
- Patent number 11,352,356
- Issue date Jun 7, 2022
- Takeda Pharmaceutical Company Limited
- Nikolaos Papaioannou
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of cellular metabolic processes
- Patent number 11,325,914
- Issue date May 10, 2022
- SERVIER PHARMACEUTICALS LLC
- Zenon D. Konteatis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of Plasma Kallikrein and uses thereof
- Patent number 11,168,083
- Issue date Nov 9, 2021
- Takeda Pharmaceutical Company Limited
- Jeremy Travins
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutically active compounds and their methods of use
- Patent number 11,021,515
- Issue date Jun 1, 2021
- Agios Pharmaceuticals, Inc
- Rene M. Lemieux
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutically active compounds and their methods of use
- Patent number 10,946,023
- Issue date Mar 16, 2021
- Agios Pharmaceuticals, Inc
- Zenon D. Konteatis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of cellular metabolic processes
- Patent number 10,800,782
- Issue date Oct 13, 2020
- Agios Pharmaceutical, Inc.
- Zenon D. Konteatis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of plasma kallikrein and uses thereof
- Patent number 10,730,874
- Issue date Aug 4, 2020
- Shire Human Genetic Therapies, Inc.
- Nikolaos Papaioannou
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutically active compounds and their methods of use
- Patent number 10,717,764
- Issue date Jul 21, 2020
- Agios Pharmaceuticals, Inc
- Janeta Popovici-Muller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and their methods of use
- Patent number 10,689,375
- Issue date Jun 23, 2020
- Agios Pharmaceuticals, Inc
- Rene M. Lemieux
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutically active compounds and their methods of use
- Patent number 10,689,414
- Issue date Jun 23, 2020
- Agios Pharmaceuticals, Inc
- Rene M. Lemieux
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutically active compositions and their methods of use
- Patent number 10,640,534
- Issue date May 5, 2020
- Agios Pharmaceuticals, Inc
- Janeta Popovici-Muller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Glutaminase inhibitors and method of use
- Patent number 10,414,740
- Issue date Sep 17, 2019
- Agios Pharmaceuticals, Inc
- Rene M. Lemieux
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2,4- or 4,6-diaminopyrimidine compounds as IDH2 mutants inhibitors...
- Patent number 10,376,510
- Issue date Aug 13, 2019
- Agios Pharmaceuticals, Inc
- Zenon D. Konteatis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of cellular metabolic processes
- Patent number 10,329,298
- Issue date Jun 25, 2019
- Agios Pharmaceuticals, Inc
- Zenon D. Konteatis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutically active compounds and their methods of use
- Patent number 10,294,215
- Issue date May 21, 2019
- Agios Pharmaceuticals, Inc
- Giovanni Cianchetta
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic compounds and compositions
- Patent number 10,202,339
- Issue date Feb 12, 2019
- Agios Pharmaceuticals, Inc
- Janeta Popovici-Muller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutically active compounds and their methods of use
- Patent number 10,172,864
- Issue date Jan 8, 2019
- Agios Pharmaceuticals, Inc
- Zenon D. Konteatis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as...
- Patent number 10,111,878
- Issue date Oct 30, 2018
- Agios Pharmaceuticals, Inc
- Jeremy Travins
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and their methods of use
- Patent number 10,087,172
- Issue date Oct 2, 2018
- Agios Pharmaceuticals, Inc
- Rene M. Lemieux
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutically active compounds and their methods of use
- Patent number 10,028,961
- Issue date Jul 24, 2018
- Agios Pharmaceuticals, Inc
- Zenon D. Konteatis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE
- Publication number 20240335448
- Publication date Oct 10, 2024
- Servier Pharmaceuticals LLC
- Zenon Konteatis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF PLASMA KALLIKREIN
- Publication number 20240226106
- Publication date Jul 11, 2024
- Nikolaos PAPAIOANNOU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROARYL INHIBITORS OF PLASMA KALLIKREIN
- Publication number 20240228488
- Publication date Jul 11, 2024
- TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Nikolaos PAPAIOANNOU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF PLASMA KALLIKREIN AND USES THEREOF
- Publication number 20240199602
- Publication date Jun 20, 2024
- Takeda Pharmaceutical Company Limited
- Jeremy Travins
- C07 - ORGANIC CHEMISTRY
Information Patent Application
POLYCYCLIC INHIBITORS OF PLASMA KALLIKREIN
- Publication number 20240199613
- Publication date Jun 20, 2024
- TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Nikolaos PAPAIOANNOU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZOPYRIDINYL INHIBITORS OF PLASMA KALLIKREIN
- Publication number 20240199612
- Publication date Jun 20, 2024
- Nikolaos PAPAIOANNOU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE
- Publication number 20240059733
- Publication date Feb 22, 2024
- Servier Pharmaceuticals LLC
- Janeta Popovici-Muller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PLASMA KALLIKREIN INHIBITORS AND USES THEREOF
- Publication number 20230391773
- Publication date Dec 7, 2023
- Takeda Pharmaceutical Company Limited
- Nikolaos Papaioannou
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE
- Publication number 20230250078
- Publication date Aug 10, 2023
- Servier Pharmaceuticals LLC
- Giovanni Cianchetta
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF PLASMA KALLIKREIN AND USES THEREOF
- Publication number 20230078513
- Publication date Mar 16, 2023
- Takeda Pharmaceutical Company Limited
- Nikolaos Papaioannou
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE
- Publication number 20220354856
- Publication date Nov 10, 2022
- AGIOS PHARMACEUTICALS, INC
- Zenon Konteatis
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE
- Publication number 20220348554
- Publication date Nov 3, 2022
- AGIOS PHARMACEUTICALS, INC
- Giovanni Cianchetta
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROARYL PLASMA KALLIKREIN INHIBITORS
- Publication number 20220298176
- Publication date Sep 22, 2022
- Takeda Pharmaceutical Company Limited
- Nikolaos Papaioannou
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AZA-HETEROBICYCLIC INHIBITORS OF MAT2A AND METHODS OF USE FOR TREAT...
- Publication number 20220098203
- Publication date Mar 31, 2022
- Les Laboratoires Servier SAS
- Zenon D. KONTEATIS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF PLASMA KALLIKREIN AND USES THEREOF
- Publication number 20220056028
- Publication date Feb 24, 2022
- Takeda Pharmaceutical Company Limited
- Jeremy Travins
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROBICYCLIC INHIBITORS OF MAT2A AND METHODS OF USE FOR TREATING...
- Publication number 20210115045
- Publication date Apr 22, 2021
- AGIOS PHARMACEUTICALS, INC
- Zenon D. KONTEATIS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PLASMA KALLIKREIN INHIBITORS AND USES THEREOF
- Publication number 20210078999
- Publication date Mar 18, 2021
- Shire Human Genetic Therapies, Inc
- Nikolaos Papaioannou
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYL PLASMA KALLIKREIN INHIBITORS
- Publication number 20210079022
- Publication date Mar 18, 2021
- Shire Human Genetic Therapies, Inc
- Nikolaos Papaioannou
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE
- Publication number 20210024575
- Publication date Jan 28, 2021
- AGIOS PHARMACEUTICALS, INC
- Janeta Popovici-Muller
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE
- Publication number 20200339626
- Publication date Oct 29, 2020
- AGIOS PHARMACEUTICALS, INC
- Rene M. Lemieux
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF PLASMA KALLIKREIN AND USES THEREOF
- Publication number 20200317667
- Publication date Oct 8, 2020
- Shire Human Genetic Therapies, Inc
- Nikolaos Papaioannou
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF PLASMA KALLIKREIN AND USES THEREOF
- Publication number 20200239463
- Publication date Jul 30, 2020
- Dyax Corp.
- Jeremy Travins
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE
- Publication number 20200079755
- Publication date Mar 12, 2020
- AGIOS PHARMACEUTICALS, INC
- Giovanni Cianchetta
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE
- Publication number 20190315802
- Publication date Oct 17, 2019
- AGIOS PHARMACEUTICALS, INC
- Janeta Popovici-Muller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF PLASMA KALLIKREIN AND USES THEREOF
- Publication number 20190284182
- Publication date Sep 19, 2019
- Shire Human Genetic Therapies, Inc
- Nikolaos Papaioannou
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF CELLULAR METABOLIC PROCESSES
- Publication number 20190233424
- Publication date Aug 1, 2019
- AGIOS PHARMACEUTICALS, INC
- Zenon D. Konteatis
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE
- Publication number 20190117661
- Publication date Apr 25, 2019
- AGIOS PHARMACEUTICALS, INC
- Zenon D. Konteatis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND THEIR METHODS OF USE
- Publication number 20190084976
- Publication date Mar 21, 2019
- AGIOS PHARMACEUTICALS, INC
- Rene M. Lemieux
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE
- Publication number 20190023737
- Publication date Jan 24, 2019
- AGIOS PHARMACEUTICALS, INC
- Rene M. Lemieux
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GLUTAMINASE INHIBITORS AND METHOD OF USE
- Publication number 20180370930
- Publication date Dec 27, 2018
- AGIOS PHARMACEUTICALS, INC
- Rene M. Lemieux
- C07 - ORGANIC CHEMISTRY

Jeremy Travins

Person

Patents Grantslast 30 patents

Plasma kallikrein inhibitors and uses thereof

Heteroaryl plasma kallikrein inhibitors

Inhibitors of cellular metabolic processes

Inhibitors of plasma kallikrein and uses thereof

Therapeutically active compounds and their methods of use

Plasma Kallikrein inhibitors and uses thereof

Therapeutically active compounds and their methods of use

Heterobicyclic inhibitors of MAT2A and methods of use for treating...

Therapeutically active compounds and their methods of use

Heteroaryl plasma kallikrein inhibitors

Inhibitors of plasma kallikrein and uses thereof

Inhibitors of cellular metabolic processes

Inhibitors of Plasma Kallikrein and uses thereof

Therapeutically active compounds and their methods of use

Therapeutically active compounds and their methods of use

Inhibitors of cellular metabolic processes

Inhibitors of plasma kallikrein and uses thereof

Therapeutically active compounds and their methods of use

Compounds and their methods of use

Therapeutically active compounds and their methods of use

Therapeutically active compositions and their methods of use

Glutaminase inhibitors and method of use

2,4- or 4,6-diaminopyrimidine compounds as IDH2 mutants inhibitors...

Inhibitors of cellular metabolic processes

Therapeutically active compounds and their methods of use

Therapeutic compounds and compositions

Therapeutically active compounds and their methods of use

N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as...

Compounds and their methods of use

Therapeutically active compounds and their methods of use

Patents Applicationslast 30 patents

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

INHIBITORS OF PLASMA KALLIKREIN

HETEROARYL INHIBITORS OF PLASMA KALLIKREIN

INHIBITORS OF PLASMA KALLIKREIN AND USES THEREOF

POLYCYCLIC INHIBITORS OF PLASMA KALLIKREIN

IMIDAZOPYRIDINYL INHIBITORS OF PLASMA KALLIKREIN

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

PLASMA KALLIKREIN INHIBITORS AND USES THEREOF

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

INHIBITORS OF PLASMA KALLIKREIN AND USES THEREOF

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

HETEROARYL PLASMA KALLIKREIN INHIBITORS

AZA-HETEROBICYCLIC INHIBITORS OF MAT2A AND METHODS OF USE FOR TREAT...

INHIBITORS OF PLASMA KALLIKREIN AND USES THEREOF

HETEROBICYCLIC INHIBITORS OF MAT2A AND METHODS OF USE FOR TREATING...

PLASMA KALLIKREIN INHIBITORS AND USES THEREOF

HETEROARYL PLASMA KALLIKREIN INHIBITORS

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

INHIBITORS OF PLASMA KALLIKREIN AND USES THEREOF

INHIBITORS OF PLASMA KALLIKREIN AND USES THEREOF

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

INHIBITORS OF PLASMA KALLIKREIN AND USES THEREOF

INHIBITORS OF CELLULAR METABOLIC PROCESSES

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

COMPOUNDS AND THEIR METHODS OF USE

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

GLUTAMINASE INHIBITORS AND METHOD OF USE